Association of Serum Triglycerides and Renal Outcomes among 1.6 Million US Veterans.

ABSTRACT:

Background

Previous studies have suggested that metabolic syndrome (MetS) components are associated with renal outcomes, defined as a decline in kidney function or reaching end-stage renal disease (ESRD). Elevated triglycerides (TGs) are a component of MetS that have been reported to be associated with renal outcomes. However, the association of TGs with renal outcomes in chronic kidney disease (CKD) patients independent of the other components of the MetS remains understudied.

Methods

We examined 1,657,387 patients with data on TGs and other components of MetS in 2004-2006 and followed up until 2014. Patients with ESRD on renal replacement therapy were excluded. We examined time to ESRD, estimated glomerular filtration rate (eGFR) slope (renal function decline), and time to

SUBMITTER: Soohoo M 

PROVIDER: S-EPMC9533458 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature